120 related articles for article (PubMed ID: 37349995)
1. Synthesis and Evaluation of Novel Substituted N-Aryl 1,4-Dihydropyridines as Antituberculostatic Agents.
Seitz L; Reiling N; Vorreiter C; Sippl W; Kessler S; Hilgeroth A
Med Chem; 2024; 20(1):30-39. PubMed ID: 37349995
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents.
Trivedi AR; Dodiya DK; Dholariya BH; Kataria VB; Bhuva VR; Shah VH
Bioorg Med Chem Lett; 2011 Sep; 21(18):5181-3. PubMed ID: 21824772
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
Sirisha K; Bikshapathi D; Achaiah G; Reddy VM
Eur J Med Chem; 2011 May; 46(5):1564-71. PubMed ID: 21382653
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents.
Khoshneviszadeh M; Edraki N; Javidnia K; Alborzi A; Pourabbas B; Mardaneh J; Miri R
Bioorg Med Chem; 2009 Feb; 17(4):1579-86. PubMed ID: 19162489
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
Desai NC; Trivedi AR; Somani HC; Bhatt KA
Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of some novel 1,4-dihydropyridines as potential antitubercular agents.
Trivedi A; Dodiya D; Dholariya B; Kataria V; Bhuva V; Shah V
Chem Biol Drug Des; 2011 Nov; 78(5):881-6. PubMed ID: 21895982
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel Enhancers of Isoniazid Toxicity in
Lentz F; Reiling N; Martins A; Molnár J; Hilgeroth A
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617279
[TBL] [Abstract][Full Text] [Related]
8. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
Venugopala KN; Deb PK; Pillay M; Chopra D; Chandrashekharappa S; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Kandeel M; Venugopala R; Mohanlall V
Curr Top Med Chem; 2021; 21(4):295-306. PubMed ID: 33138763
[TBL] [Abstract][Full Text] [Related]
9. Facile synthesis and antibacterial, antitubercular, and anticancer activities of novel 1,4-dihydropyridines.
Sirisha K; Achaiah G; Reddy VM
Arch Pharm (Weinheim); 2010 Jun; 343(6):342-52. PubMed ID: 20496343
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel N-phenyl 1,4-dihydropyridines with a dual mode of antimycobacterial activity.
Lentz F; Hemmer M; Reiling N; Hilgeroth A
Bioorg Med Chem Lett; 2016 Dec; 26(24):5896-5898. PubMed ID: 27866817
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1.
Juhás M; Pallabothula VSK; Grabrijan K; Šimovičová M; Janďourek O; Konečná K; Bárta P; Paterová P; Gobec S; Sosič I; Zitko J
Bioorg Chem; 2022 Jan; 118():105489. PubMed ID: 34826708
[TBL] [Abstract][Full Text] [Related]
13. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
14. Dually Acting Nonclassical 1,4-Dihydropyridines Promote the Anti-Tuberculosis (Tb) Activities of Clofazimine.
Lentz F; Reiling N; Spengler G; Kincses A; Csonka A; Molnár J; Hilgeroth A
Molecules; 2019 Aug; 24(16):. PubMed ID: 31398786
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
Němeček J; Sychra P; Macháček M; Benková M; Karabanovich G; Konečná K; Kavková V; Stolaříková J; Hrabálek A; Vávrová K; Soukup O; Roh J; Klimešová V
Eur J Med Chem; 2017 Apr; 130():419-432. PubMed ID: 28279848
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents.
Desai B; Sureja D; Naliapara Y; Shah A; Saxena AK
Bioorg Med Chem; 2001 Aug; 9(8):1993-8. PubMed ID: 11504636
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
18. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis.
Surineni G; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2015 Feb; 25(3):485-91. PubMed ID: 25559743
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids.
Wächter GA; Davis MC; Martin AR; Franzblau SG
J Med Chem; 1998 Jun; 41(13):2436-8. PubMed ID: 9632376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
